Faeth Therapeutics, Inc. (FTH) stock

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30

$13.35+0.43 (+3.33%)

Close on Nov 11, 2026Market cap $344.97MP/E –Yield –

Faeth Therapeutics statistics

64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 29, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $344.97M; $282.97M
Enterprise Value: $158.53M; $154.96M
PB Ratio: 1.99; 2.17
P/TBV Ratio: 1.99; 2.39

Share statisticsIndustry

Shares Outstanding: 26M; 58M
Shares Change (YoY): 87.9%; 10.9%
Shares Change (QoQ): 1827.3%; 0.51%
Float: 21M; 49M
Shares Held by Insiders: 17.2%; 11.6%
Shares Held by Institutions: 54.5%; 56.4%

Short sellingIndustry

Short Interest: 3M; –
Short Interest Change: 17.7%; -0.76%
Short % of Float: 12.8%; 9.06%
Short % of Shares Outstanding: 10.6%; 6.38%
Days to Cover: 6.31; 5.16

Stock price statisticsIndustry

52-Week High: $42.14; –
52-Week Low: $7.45; –
20-Day Moving Average: $18.49; –
50-Day Moving Average: $26.22; –
200-Day Moving Average: $25.42; –
Average True Range (14): $2.71; –
Price Change (1 Week): -33.2%; -0.50%
Price Change (1 Month): -37.9%; -0.33%
Price Change (3 Months): -53.2%; -17.2%
Price Change (6 Months): -36.7%; -20.1%
Price Change (YTD): 25.1%; -20.1%
Price Change (1 Year): 38.9%; -19.3%
Price Change (3 Years): -7.29%; -23.4%
Price Change (5 Years): -93.1%; -76.4%
Average Volume (10 Days): 905,413; –
Average Volume (20 Days): 667,199; –
Average Volume (90 Days): 417,697; –
Relative Volume: 3.37; 0.73
Relative Strength Index (14): 30.9; 47.6
Volatility (1 Year): 223.6%; 80.2%
Beta (5 Years): 1.31; 1.07

Returns on capitalIndustry

Return on Equity (ROE): -195.3%; -51.3%
Return on Assets (ROA): -176.9%; -40.3%
Return on Capital Employed (ROCE): -110.6%; -37.7%

Financial positionIndustry

Current Ratio: 19.69; 3.30
Quick Ratio: 19.46; 2.37

EfficiencyIndustry

Profits Per Employee: -$6.74M; -$680.86K
Employee Count: 29; 75
WACC: 11.4%; 10.1%

Income statement (TTM)Industry

Operating Income: -$198.82M; -$20.20M
Net Income: -$195.53M; -$21.57M
EBITDA: -$198.71M; -$16.36M
EPS (Diluted): -$141.65; -$0.77

Balance sheetIndustry

Cash & Short-Term Investments: $186.44M; $65.30M
Net Cash (Debt): $186.44M; $16.31M
Net Cash Per Share: $7.22; $0.70
Equity (Book Value): $172.96M; $53.12M
Book Value Per Share: $6.69; $1.49
Tangible Book Value: $172.96M; $26.11M
Working Capital: $179.08M; $77.59M

Cash flow (TTM)Industry

Operating Cash Flow: -$33.86M; -$12.07M
Capital Expenditures: -$6.00K; -$939.00K
Free Cash Flow: -$33.86M; -$18.37M
FCF Per Share: -$1.31; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -56.7%; -19.8%
FCF Yield: -9.82%; -8.81%

Taxes and interestIndustry

Income Tax: $0; $79.50K

Scores and fair valueIndustry

Altman Z-Score: 15.80; 0.28
Piotroski F-Score: 1; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	FTH	S&P 500	Difference	FTH per year	S&P 500 per year
1 month	-48.7%	-2.4%	−46.3 pts
3 months	-55.5%	-1.2%	−54.3 pts
Year to date	+25.1%	+12.3%	+12.8 pts
1 year	+39.6%	+12.4%	+27.1 pts
3 years	-7.3%	+78.8%	−86.1 pts	-2.5%	+21.4%
5 years	-92.3%	+75.2%	−167.5 pts	-40.1%	+11.9%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M FTH shares were sold short on Oct 30, 2026, up 17.7% from the previous report, or 12.76% of the shares available to trade. At recent volumes it would take 6.3 days to buy them back. Over the last 20 sessions, 43.7% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	2,730,889	+17.7%	432,468	6.3
Oct 15, 2026	2,320,706	+12.2%	297,820	7.8
Sep 30, 2026	2,067,445	+56.8%	569,389	3.6
Sep 15, 2026	1,318,893	+20.1%	301,783	4.4
Aug 31, 2026	1,098,324	+32.8%	299,621	3.7
Aug 14, 2026	827,167	+1.4%	300,902	2.8
Jul 31, 2026	815,587	-8.4%	289,922	2.8
Jul 15, 2026	890,306	+14.1%	235,950	3.8
Jun 30, 2026	780,396	+26.8%	112,285	7.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?